Patients with obstructive sleep apnea have suppressed levels of soluble cytokine receptors involved in neurodegenerative disease, but normal levels with airways therapy
- PMID: 33037528
- PMCID: PMC8376707
- DOI: 10.1007/s11325-020-02205-y
Patients with obstructive sleep apnea have suppressed levels of soluble cytokine receptors involved in neurodegenerative disease, but normal levels with airways therapy
Abstract
Purpose: Obstructive sleep apnea (OSA) results in systemic intermittent hypoxia. By one model, hypoxic stress signaling in OSA patients alters the levels of inflammatory soluble cytokines TNF and IL6, damages the blood brain barrier, and activates microglial targeting of neuronal cell death to increase the risk of neurodegenerative disorders and other diseases. However, it is not yet clear if OSA significantly alters the levels of the soluble isoforms of TNF receptors TNFR1 and TNFR2 and IL6 receptor (IL6R) and co-receptor gp130, which have the potential to modulate TNF and IL6 signaling.
Methods: Picogram per milliliter levels of the soluble isoforms of these four cytokine receptors were estimated in OSA patients, in OSA patients receiving airways therapy, and in healthy control subjects. Triplicate samples were examined using Bio-Plex fluorescent bead microfluidic technology. The statistical significance of cytokine data was estimated using the nonparametric Wilcoxon rank-sum test. The clustering of these high-dimensional data was visualized using t-distributed stochastic neighbor embedding (t-SNE).
Results: OSA patients had significant twofold to sevenfold reductions in the soluble serum isoforms of all four cytokine receptors, gp130, IL6R, TNFR1, and TNFR2, as compared with control individuals (p = 1.8 × 10-13 to 4 × 10-8). Relative to untreated OSA patients, airways therapy of OSA patients had significantly higher levels of gp130 (p = 2.8 × 10-13), IL6R (p = 1.1 × 10-9), TNFR1 (p = 2.5 × 10-10), and TNFR2 (p = 5.7 × 10-9), levels indistinguishable from controls (p = 0.29 to 0.95). The data for most airway-treated patients clustered with healthy controls, but the data for a few airway-treated patients clustered with apneic patients.
Conclusions: Patients with OSA have aberrantly low levels of four soluble cytokine receptors associated with neurodegenerative disease, gp130, IL6R, TNFR1, and TNFR2. Most OSA patients receiving airways therapy have receptor levels indistinguishable from healthy controls, suggesting a chronic intermittent hypoxia may be one of the factors contributing to low receptor levels in untreated OSA patients.
Keywords: Airways therapy; CPAP; Cytokines; Microglia; Neurodegenerative disease; OSA; Obstructive sleep apnea.
© 2020. The Author(s).
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures


Similar articles
-
CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea.Eur Respir J. 2008 Oct;32(4):1009-15. doi: 10.1183/09031936.00007008. Epub 2008 May 28. Eur Respir J. 2008. PMID: 18508832 Clinical Trial.
-
Airways therapy of obstructive sleep apnea dramatically improves aberrant levels of soluble cytokines involved in autoimmune disease.Clin Immunol. 2020 Dec;221:108601. doi: 10.1016/j.clim.2020.108601. Epub 2020 Oct 2. Clin Immunol. 2020. PMID: 33017651 Clinical Trial.
-
Serum from obstructive sleep apnea patients induces inflammatory responses in coronary artery endothelial cells.Atherosclerosis. 2016 Nov;254:59-66. doi: 10.1016/j.atherosclerosis.2016.09.017. Epub 2016 Sep 22. Atherosclerosis. 2016. PMID: 27693879 Free PMC article.
-
Impact of continuous positive airway pressure on vascular endothelial growth factor in patients with obstructive sleep apnea: a meta-analysis.Sleep Breath. 2019 Mar;23(1):5-12. doi: 10.1007/s11325-018-1660-4. Epub 2018 Apr 18. Sleep Breath. 2019. PMID: 29671205 Review.
-
The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension.Curr Hypertens Rep. 2014 Jan;16(1):411. doi: 10.1007/s11906-013-0411-y. Curr Hypertens Rep. 2014. PMID: 24346827 Review.
Cited by
-
An Overview of the Obese-Asthma Phenotype in Children.Int J Environ Res Public Health. 2022 Jan 6;19(2):636. doi: 10.3390/ijerph19020636. Int J Environ Res Public Health. 2022. PMID: 35055456 Free PMC article. Review.
-
Cellular Immune Dysfunction in Obstructive Sleep Apnea.Front Surg. 2022 Jul 6;9:890377. doi: 10.3389/fsurg.2022.890377. eCollection 2022. Front Surg. 2022. PMID: 35874140 Free PMC article. Review.
-
Patients with Obstructive Sleep Apnea Have Altered Levels of Four Cytokines Associated with Cardiovascular and Kidney Disease, but Near Normal Levels with Airways Therapy.Nat Sci Sleep. 2021 Mar 25;13:457-466. doi: 10.2147/NSS.S282869. eCollection 2021. Nat Sci Sleep. 2021. PMID: 33790678 Free PMC article.
-
Two-sample bi-directional causality between two traits with some invalid IVs in both directions using GWAS summary statistics.HGG Adv. 2025 Jul 10;6(3):100449. doi: 10.1016/j.xhgg.2025.100449. Epub 2025 May 6. HGG Adv. 2025. PMID: 40336198 Free PMC article.
-
Sex Differences in 90-Day Functional Outcomes for Acute Ischemic Stroke Patients With Obstructive Sleep Apnea.Cureus. 2023 May 29;15(5):e39652. doi: 10.7759/cureus.39652. eCollection 2023 May. Cureus. 2023. PMID: 37388591 Free PMC article.
References
-
- Neikrug AB, Liu L, Avanzino JA, Maglione JE, Natarajan L, Bradley L, Maugeri A, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S. Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea. Sleep. 2014;37(1):177–185. doi: 10.5665/sleep.3332. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials